SETD2 drives METTL14-mediated m6A to suppress Piezo1 Attenuation and activate TGM2 to promote pulmonary hypertension
Abstract Background Pulmonary arterial hypertension (PAH) is characterized by pathological vascular remodeling driven by pulmonary artery smooth muscle cell (PASMC) proliferation. While METTL14-mediated N6-methyladenosine (m6A) RNA modification has been implicated in PAH, the upstream regulators and...
Saved in:
| Main Authors: | Shuai-shuai Zhao, Chuan Yuan, Jin-long Liu, Qi-cai Wu, Xue-liang Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-08-01
|
| Series: | Cellular and Molecular Life Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s00018-025-05809-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of METTL14 overcomes CDK4/6 inhibitor resistance driven by METTL14-m6A-E2F1-axis in ERα-positive breast cancer
by: Chenlin Liu, et al.
Published: (2025-01-01) -
METTL14 and WTAP play a crucial role in the regulation of bovine preadipocyte differentiation
by: Jia Liu, et al.
Published: (2025-12-01) -
METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer
by: Lijie Li, et al.
Published: (2024-12-01) -
Specific sDMA modifications on the RGG/RG motif of METTL14 regulate its function in AML
by: Yulun Zhong, et al.
Published: (2025-03-01) -
Up-regulation of m6A writer METTL14 inhibits tumorigenesis by suppressing glycolysis in colorectal cancer
by: Lulu Li, et al.
Published: (2025-02-01)